Multiple myeloma differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Multiple myeloma must be differentiated from [[monoclonal gammopathy of undetermined significance]] (MGUS), isolated plasmacytoma of the bone, and [[extramedullary plasmacytoma]].<ref name="seer">{{Cite web  | last =  | first =  | title = Myeloma - SEER Stat Fact Sheets | url = http://seer.cancer.gov/statfacts/html/mulmy.html | publisher =  | date =  | accessdate = 17 February 2014 }}</ref>
Multiple myeloma must be differentiated from osteoporosis, osteomalacia, scurvy, osteogenesis imperfecta, and homocystinuria. Each condition has unique causes, features, and treatments.


==Differentiating Multiple Myeloma from other Diseases==
==Differentiating Multiple Myeloma from other Diseases==

Revision as of 00:15, 19 August 2018

Multiple myeloma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple Myeloma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Multiple myeloma differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple myeloma differential diagnosis

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple myeloma differential diagnosis

CDC on Multiple myeloma differential diagnosis

Multiple myeloma differential diagnosis in the news

Blogs on Multiple myeloma differential diagnosis

Directions to Hospitals Treating Multiple myeloma

Risk calculators and risk factors for Multiple myeloma differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2] Shyam Patel [3]

Overview

Multiple myeloma must be differentiated from osteoporosis, osteomalacia, scurvy, osteogenesis imperfecta, and homocystinuria. Each condition has unique causes, features, and treatments.

Differentiating Multiple Myeloma from other Diseases

  • The table below summarizes how to differentiate multiple myeloma from other conditions that have a similar presentation:[1]
Differential Diagnosis Causes Features Therapy
Multiple myeloma
  • Chromosomal aberrations or other genetic insults
  • Malignant transformation of plasma cells
  • Clonal plasma cell proliferation
  • Induction chemotherapy with bortezomib, lenalidomide, and dexamethasone
  • Bisphosphonates
  • RANK ligand inhibitors (denosumab)
  • Autologous stem cell transplantation
Osteoporosis
  • Imbalance between bone resorption and bone formation
  • Preceded by osteopenia
  • Decreased bone mineral density
  • Acute musculoskletal pain if fractures develop
  • Severe decrease in BMD on dual-energy X-ray absorptiometry (DEXA) test
  • T score less than -2.5 on DEXA scan
  • Calcium and vitamin D supplementation
  • Bisphosphonates
  • Weight-bearing exercise
  • Teriparatide
  • RANK ligand inhibitors (denosumab)
Osteomalacia[2]
  • Inadequate mineralization of bone
  • Deficiencies in vitamin D, calcium, or phosphorus
  • Renal tubular acidosis
  • Malabsorption
  • Vitamin D3 supplementation
Scurvy
  • Vitamin C deficiency
  • Malabsorption
  • Hemodialysis
  • Gum disease
  • Loose teeth
  • Easy bruising
  • Vitamin C supplementation
  • Citrus fruits
Osteogenesis imperfecta[3]
  • Mutations in COL1A1 or COL1A2
  • Impaired type I collagen synthesis
  • Bisphosphonates
  • Physical therapy
  • Surgical fixation of brittle bones
  • Genetic counseling for offspring
Homocystinuria[4]
  • Deficiency of cystathione beta synthase
  • Deficiency of folate, vitamin B12, or vitamin B6
  • High-dose vitamin B6 supplementation
  • Betaine supplementation

References

  1. "Myeloma - SEER Stat Fact Sheets". Retrieved 17 February 2014.
  2. Zuo QY, Wang H, Li W, Niu XH, Huang YH, Chen J; et al. (2017). "Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients". BMC Musculoskelet Disord. 18 (1): 403. doi:10.1186/s12891-017-1756-1. PMC 5609032. PMID 28934935.
  3. Shaker JL, Albert C, Fritz J, Harris G (2015). "Recent developments in osteogenesis imperfecta". F1000Res. 4 (F1000 Faculty Rev): 681. doi:10.12688/f1000research.6398.1. PMC 4566283. PMID 26401268.
  4. Kumar A, Palfrey HA, Pathak R, Kadowitz PJ, Gettys TW, Murthy SN (2017). "The metabolism and significance of homocysteine in nutrition and health". Nutr Metab (Lond). 14: 78. doi:10.1186/s12986-017-0233-z. PMC 5741875. PMID 29299040.


Template:WikiDoc Sources